Loading stock data…
Alpha Cognition Inc. (ACOG)
$7.90-0.33 (-4.01%)
Market ClosedLast close Jul 24
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Alpha Cognition Inc. Common Stock in the Healthcare sector is trading at $7.90 with a market capitalization of $132M. Wall Street consensus targets $16.00 (4 analysts), implying a +102.5% move over the next 12 months. The stock is currently 22% below its 52-week high of $10.15, remaining 26.6% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +102.5% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.53M↑ | $2.79M↓ | $2.84M↑ | $1.66M↓ | $2.93M |
| Gross Profit | $3.26M↑ | $2.54M↑ | $2.21M↑ | $1.12M↓ | $2.09M |
| Operating Income | -$8.10M↓ | -$7.93M↓ | -$5.30M↑ | -$5.74M↓ | -$3.33M |
| Net Income | -$6.48M↑ | -$6.86M↓ | -$1.32M↑ | -$10.49M↓ | -$1.73M |
Peer Comparison
JNJUNHPFE
Fundamentals
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tab...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$132.39M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-43.76%
Volume
Today's trading volume
29,283
Recent News
Time to Jump In? Raymond James Is Bullish on These 2 Stocks
Geopolitics have been making headlines again – war in the Middle East and uncertainty in the price of oil are stirring up the headwinds. Yet, the S&P 500 has remained resilient, supported by strong corporate earnings. During the first-quarter earnings season, tech companies helped drive overall year-over-year earnings growth of 28.6%, the strongest quarter since late 2021, and expectations remain high for the second quarter, with FactSet forecasting earnings growth above 20% for a second consecu
Raymond James Starts Alpha Cognition (ACOG) at Outperform
Alpha Cognition Inc. (NASDAQ:ACOG) is one of the 10 High Growth Stocks Insiders Are Buying. On July 10, 2026, Raymond James analyst Ryan Deschner initiated coverage of Alpha Cognition Inc. (NASDAQ:ACOG) with an Outperform rating and $20 price target. Deschner noted that Alpha Cognition markets Zunveyl, a prodrug of FDA-approved galantamine indicated for the treatment […]
Alpha Cognition (ACOG) Stock Fair Value Moves Lower As Analysts Weigh Zunveyl Persistence
Alpha Cognition’s consolidated fair value target has been reset from about US$20.00 to roughly US$14.67, a change of around US$5.33 per share that reframes how the stock’s upside and risk are being weighed. This shift sits alongside analyst commentary highlighting that high failure and switch rates in existing Alzheimer’s therapies may limit how quickly the market is prepared to assign higher multiples to products such as ZUNVEYL. Read on to see how this updated narrative is evolving and how...
We Think Alpha Cognition (NASDAQ:ACOG) Needs To Drive Business Growth Carefully
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Alpha Cognition Inc. (NASDAQ:ACOG) Just Reported, And Analysts Assigned A US$16.00 Price Target
Last week saw the newest first-quarter earnings release from Alpha Cognition Inc. ( NASDAQ:ACOG ), an important...